Gynecologic Cancer,Other Cancers Olaparib Plus Bevacizumab Efficacy Predicted in First-Line Ovarian Cancer Using HR Gene Mutations May 22, 2023
Gastrointestinal Cancer,Other Cancers 177Lu-DOTA0-Tyr3-Octreotate vs. Octreotide LAR in Somatostatin Receptor Positive Tumours May 22, 2023
Other Cancers Efficacy of Surufatinib in Treating Advanced Pancreatic NETs Assessed in the SANET-p Phase-3 Study May 16, 2023
Breast Cancer,Other Cancers Ribociclib vs Abemaciclib: Quality of Life in HR+/HER2- Advanced Breast Cancer May 16, 2023
Gastrointestinal Cancer,Other Cancers Phase Ib Safety and Efficacy of Cabozantinib+Durvalumab in Gastrointestinal Malignancies May 16, 2023
Genitourinary Cancer,Other Cancers KEYNOTE-426: HRQoL of Pembrolizumab+Axitinib vs Sunitinib in RCC May 16, 2023
Genitourinary Cancer,Other Cancers Latest Update on LITESPARK-022 Phase-3 Study of Belzutifan and Pembrolizumab in ccRCC May 16, 2023
